Details for 2012833767
Up to date per 04.04.2026
Actions
Details for 2012833767
Granted/Registered
European Patent
30.07.2014 A
31.10.2018 B1
23.09.2011
US
201161538454 P
10.02.2012
US
201261597409 P
24.08.2012
US
201261692978 P
A61K 39/00 20060101AFI20150323BHEP
Owner
OncoMed Pharmaceuticals, Inc.800 Chesapeake Drive Redwood City, CA 94063US
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
GURNEY, Austin L.946 Diamond Street San Francisco, CA 94114US
SATO, Aaron Ken1640 Coronado Way Burlingame, CA 94010US
BOND, Christopher John511 30th Avenue San Mateo, CA 94403US
Information about Fees